City

Chapel Hill (1)

Copenhagen (1)

Kampala (1)

Condition

Postpartum Psychosis (3)

Major Depressive Disorder (1)

Menopause (1)

Neurodegeneration (1)

Postpartum Depression (1)

Schizophrenia (1)

Overall Status

Completed (1)

Recruiting (1)

Unknown status (1)

Phase

n/a (2)

early phase 1 (1)

Sponsor

Gitte Moos Knudsen (1)

Makerere University (1)

University of North Carolina, Chapel Hill (1)

Collaborator

CNSR, Glostrup Psychiatric Center (1)

Center for Integrated Molecular Brain Imaging, Copenhagen, Denmak (1)

Danish Multiple Sclerosis Center Rigshospitalet (1)

Dept. of Clinical Immunology, Rigshospitalet (1)

Fertility Clinic Rigshospitalet (1)

Sage Therapeutics (1)

Swedish International Development Cooperation Agency (SIDA) (1)

Intervention

brexanolone (1)

drug compliance (1)

encouragement of drug compliance (1)

family psychoeducation (1)

goserelin 3.6 mg implant (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

behavioral (1)

Funder Type

Other (3)

Study Type

Interventional (3)

postpartum psychosis

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Postpartum Psychosis Trial in Chapel Hill (Brexanolone)

Recruiting

Postpartum Psychosis

Brexanolone

Chapel Hill, North Carolina

UNC Hospitals

Mar 28, 2022

Postpartum Depression, MDD, Postpartum Psychosis Trial in Copenhagen (Goserelin 3.6 mg implant, Placebo)

Completed

Postpartum Depression
+5 more

Goserelin 3.6 mg implant
Placebo

Copenhagen, Denmark

Neurobiology Research Unit, Rigshospitalet

Jan 19, 2016

Postpartum Psychosis Trial in Kampala (drug compliance, Encouragement of drug compliance, Family psychoeducation)

Unknown status

Postpartum Psychosis

drug compliance
+2 more

Kampala, Uganda
+1 more

Jul 28, 2010